Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

SpirH begins phase II study and opens enrollment for worldwide clinic participation

Oct. 16, 2007

FDA approves Isentress tablets for combination treatment of HIV-1

Oct. 15, 2007

Pooled DUET results show TMC-125 well tolerated in HIV-infected patients

Oct. 15, 2007

KP-1461 safe and well tolerated in phase I study in HIV patients

Oct. 11, 2007

Aptivus receives full FDA approval as part of combination therapy for HIV

Oct. 9, 2007

One-year treatment with tesamorelin shows promise in phase III trial

Oct. 4, 2007

Update on Pfizer's study of CCR5 antagonist Selzentry for HIV

Oct. 1, 2007

Novel class of HIV-1 integrase inhibitors with distinct mechanism of strand transfer inhibition

Oct. 1, 2007

U.S. awards USD 15 million to GeoVax's HIV/AIDS vaccine program

Oct. 1, 2007

INCB-9471 safe and well tolerated in clinical studies

Sep. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...